pharma · Psoriasis · EGFR Positive Non-small Cell Lung Cancer
Betta Pharmaceuticals Co
Betta Pharmaceuticals Co.,
Betta Pharmaceuticals Co is a pharma organization headquartered in CN. Primary therapeutic focus areas include Psoriasis, EGFR Positive Non-small Cell Lung Cancer. NovaPharmaNews links 2 clinical program(s), 0 drug profi
Hangzhou, CN HQ
23 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Hangzhou, CN
- Employees
- 23
- Programs
- 2
- Drugs
- 4
- Patents
- 0
1% icotinib hydrochloride cream
Phase 1 · small molecule · Psoriasis
1% icotinib hydrochloride cream for Psoriasis is a Phase 1 program (small_molecule) at Betta Pharmaceuticals Co., with 1 ClinicalTrials.gov record(s).
Internal code BD-ICC-NZ-I01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Betta Pharmaceuticals Co.,
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Psoriasis
- Status
- completed
- Trials
- 1